Clinical utility of intraocular pressure monitoring outside of normal office hours in patients with glaucoma

Archives of Ophthalmology

Volumn 124, Issue 6, 2006, Pages 793-797

  Barkana, Yaniv ^a   Anis, Sarah ^a   Liebmann, Jeffrey ^c,d   Tello, Celso ^a,b   Ritch, Robert ^a,b  

^a NEW YORK EYE AND EAR INFIRMARY   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d EAR AND THROAT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; PRIORITY JOURNAL; REVIEW; SUPINE POSITION; TIME; TRABECULECTOMY; TRABECULOPLASTY; VISUAL FIELD;

AGED; ANTIHYPERTENSIVE AGENTS; CIRCADIAN RHYTHM; DISEASE PROGRESSION; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MONITORING, PHYSIOLOGIC; POSTURE;

EID: 33745043449     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.124.6.793     Document Type: Review

References (32)

1. Higginbotham EJ, Gordon MO, Beiser JA, et al; Ocular Hypertension Treatment Study Group. The Ocular Hypertension Treatment Study: topical medication delays or prevents primary open-angle glaucoma in African American individuals. Arch Ophthalmol. 2004;122:813-820.
2. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E; Early Manifest Glaucoma Trial Group. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003;121:48-56.
3. AGIS Investigators. Advanced Glaucoma Intervention Study (AGIS), 7: the relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000;130:429-440.
4. Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:714-720.
5. Drance SM. Diurnal variation of intraocular pressure in treated glaucoma: significance in patients with chronic simple glaucoma. Arch Ophthalmol. 1963;70:302-311.
6. Hughes E, Spry P, Diamond J. 24-Hour monitoring of intraocular pressure in glaucoma management: a retrospective review. J Glaucoma. 2003;12:232-236.
7. Wax MB, Camras CB, Fiscella RG, Girkin C, Singh K, Weinreb RN. Emerging perspectives in glaucoma: optimizing 24-hour control of intraocular pressure. Am J Ophthalmol. 2002;133(suppl):S1-S10.
8. Henkind P, Leitman M, Weitzman E. The diurnal curve in man: new observations. Invest Ophthalmol. 1973;12:705-707.
9. Kitazawa Y, Horie T. Diurnal variation of intraocular pressure in primary openangle glaucoma. Am J Ophthalmol. 1975;79:557-566.
10. David R, Zangwill L, Briscoe D, Dagan M, Yagev R, Yassur Y. Diurnal intraocular pressure variations: an analysis of 690 diurnal curves. Br J Ophthalmol. 1992;76:280-283.
11. De Vivero C, O'Brien C, Lanigan L, Hitchings R. Diurnal intraocular pressure variation in low-tension glaucoma. Eye. 1994;8:521-523.
12. Rota-Bartelink AM, Pitt A, Story I. Influence of diurnal variation on the intraocular pressure measurement of treated primary open-angle glaucoma during office hours. J Glaucoma. 1996;5:410-415.
13. Liu JH, Kripke DF, Hoffman RE, et al. Nocturnal elevation of intraocular pressure in young adults. Invest Ophthalmol Vis Sci. 1998;39:2707-2712.
14. Liu JH, Kripke DF, Twa MD, et al. Twenty-four-hour pattern of intraocular pressure in the aging population. Invest Ophthalmol Vis Sci. 1999;40:2912-2917.
15. Liu JH, Bouligny RP, Kripke DF, Weinreb RN. Nocturnal elevation of intraocular pressure is detectable in the sitting position. Invest Ophthalmol Vis Sci. 2003;44:4439-4442.
16. Liu JH, Zhang X, Kripke DF, Weinreb RN. Twenty-four-hour intraocular pressure pattern associated with early glaucomatous changes. Invest Ophthalmol Vis Sci. 2003;44:1586-1590.
17. Mosaed S, Liu JH, Weinreb RN. Correlation between office and peak nocturnal intraocular pressures in healthy subjects and glaucoma patients. Am J Ophthalmol. 2005;139:320-324.
18. Asrani S, Zeimer R, Wilensky J, Gieser D, Vitale S, Lindenmuth K. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma. 2000;9:134-142.
19. Nouri-Mahdavi K, Hoffman D, Coleman AL, et al; Advanced Glaucoma Intervention Study. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology. 2004;111:1627-1635.
20. Kass MA, Meltzer DW, Gordon M, Cooper D, Goldberg J. Compliance with topical pilocarpine treatment. Am J Ophthalmol. 1986;101:515-523.
21. Flammer J, Haefliger IO, Orgül S, Resink T. Vascular dysregulation: a principal risk factor for glaucomatous damage? J Glaucoma. 1999;8:212-219.
22. Flammer J, Orgül S, Costa VP, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res. 2002;21:359-393.
23. Zeimer RC, Wilensky JT, Gieser DK. Presence and rapid decline of early morning intraocular pressure peaks in glaucoma patients. Ophthalmology. 1990;97:547-550.
24. Konstas AG, Mantziris DA, Stewart WC. Diurnal intraocular pressure in untreated exfoliation and primary open-angle glaucoma. Arch Ophthalmol. 1997;115:182-185.
25. Ido T, Tomita G, Kitazawa Y. Diurnal variation of intraocular pressure of normaltension glaucoma: influence of sleep and arousal. Ophthalmology. 1991;98:296-300.
26. Orzalesi N, Rossetti L, Invernizzi T, Bottoli A, Autelitano A. Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension. Invest Ophthalmol Vis Sci. 2000;41:2566-2573.
27. Orzalesi N, Rossetti L, Bottoli A, Fumagalli E, Fogagnolo P. The effect of latanoprost, brimonidine, and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with glaucoma or ocular hypertension. Arch Ophthalmol. 2003;121:453-457.
28. Konstas AG, Mylopoulos N, Karabatsas CH, et al. Diurnal intraocular pressure reduction with latanoprost 0.005% compared to timolol maleate 0.5% as monotherapy in subjects with exfoliation glaucoma. Eye. 2004;18:893-899.
29. Liu JH, Kripke DF, Weinreb RN. Comparison of the nocturnal effects of oncedaily timolol and latanoprost on intraocular pressure. Am J Ophthalmol. 2004;138:389-395.
30. Larsson LI, Mishima HK, Takamatsu M, Orzalesi N, Rossetti L. The effect of latanoprost on circadian intraocular pressure. Surv Ophthalmol. 2002;47(suppl 1):S90-S96.
31. Shah S, Spedding C, Bhojwani R, Kwartz J, Henson D, McLeod D. Assessment of the diurnal variation in central corneal thickness and intraocular pressure for patients with suspected glaucoma. Ophthalmology. 2000;107:1191-1193.
32. Wickham L, Edmunds B, Murdoch IE. Central corneal thickness: will one measurement suffice? Ophthalmology. 2005;112:225-228.